The Berry Consultants Software team is excited to announce a new release of ADDPLAN neo, version 10.2.

This new release adds a graph for Group Sequential designs as well as shows the stopping boundaries, superimposes the estimates of the test statistic at interims from 100…

For next week’s FACTS Software March Webinar, the team will look at Response Adaptive Randomization (RAR) in practice, misconceptions, and simulated examples in both R and FACTS. You will not want to miss it!

For advance Zoom registration for the March 22, 11am EDT session,…

So honored & humbled to be part of REMAP-ILD
A consortium committed to bringing more efficiency to research in interstitial lung diseases #ILD #pulmonaryfibrosis

Our pts deserve smarter/more efficient trials. Thanks Berry Consultants for being on board this adventure

Berry Consultants will be presenting on two topics at next week’s 2024 ENAR Spring Meeting ENAR On March 11 at 9:20am EST, Joe Marion, Ph.D., will be presenting “Borrowing Phase 2 Data in Phase 3: Case Study from the PUNCH CD3 Trial” during Session 22 (8:30am – 10:15am).…

1/ Hot off the press 💥 #REMAPILD concept and foundations now published on ThoraxBMJ

Result of the effort of so many people! Kudos everyone to push for more efficient research in ILD!

Special thanks to Berry Consultants Action for Pulmonary Fibrosis EU-PFF +

thorax.bmj.com/content/early/…

Don’t miss Berry Consultants presenting at the upcoming International Society for Biopharmaceutical Statistics (ISBS) Symposium this week. On March 8th, Christina Saunders, Ph.D., will be presenting “Successful Implementation of Adaptive Analyses for Platform Trials: A…

Berry Consultants will be hosting a free public webinar on the optimization of a clinical trial design by estimating its impact on the expected net present value (or ROI) of a drug development program using the software, QUOTES (Quantification and Optimization of Trial…

💡 Thanks to REMAP-CAP's smart design, patients can be randomized to multiple domains, hence the # of randomizations far exceeds the # of patients.

Increased efficiency → faster results & uptake → bigger impact 🎯

See the latest stats 👉 remapcap.org

Precision Promise (Pancreatic Cancer) completes stage 2 for pamrevlumab. Congrats to the Precision Promise team! PanCAN Berry Consultants Global Coalition for Adaptive Research Results still pending, but an explainer on the current status
berryconsultants.com/2024/01/26/blo…

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer globenewswire.com/en/news-releas…

$PAA has partnered with leading #MND / #ALS clinical study design & statistical analysis specialists Berry Consultants, who will oversee the design of our adaptive Phase 2/3 study to best position monepantel for FDA approval for the treatment of MND/ALS: tinyurl.com/3td89s4r

FDA Draft master protocol guidance is out. Here is a blog post with some details on the content, and where I expect to hear the most discussion. I encourage everyone to make comments reflecting your experiences and knowledge.
berryconsultants.com/2024/01/11/blo…

The Berry Consultants software team will be hosting its January FACTS webinar next Friday, January 19 at 11am EST to present the development plans for adding an ordinal endpoint option to the trial simulator. For anyone interested in learning more about FACTS and its plans,…

Registration is now OPEN for this exciting new event on Response-Adaptive Randomisation in #clinicaltrials , with fantastic line-up of speakers, organised by Sofia S. Villar & David Robertson.

29 Feb, Cambridge

Register👇
onlinesales.admin.cam.ac.uk/conferences-an…

Join Dr. Barbara Wendelberger of Berry Consultants at 11am PDT Nov. 3rd at #ISTSS2203 in a panel discussion: “Stepping into the Future with Development of Precision Medicine Based Therapeutics for PTSD: Introducing the DOD Adaptive Platform Trial for PTSD Launching 2023”.

Scott Berry, from Berry Consultants, & Danny McAuley Danny McAuley from Queen's University Belfast Queen's University Belfast 🎓 join Rob Mac Sweeney to discuss the results of the statin domain of the remap-cap trial on the CCR Podcast

ESICM #LIVES2023 NEJM

criticalcarereviews.com/podcasts/remap…

📣 2 major new REMAP-CAP papers were released moments ago!

📄 Intravenous #VitaminC for Patients Hospitalized with #COVID19 : Two Harmonized Randomized Clinical Trials 👉 jamanetwork.com/journals/jama/…

📄 #Simvastatin in Critically Ill Patients with COVID-19 👉 nejm.org/doi/full/10.10…

Berry Consultants is proud to sponsor the @Amstatnews Women in Statistics and Data Science Conference next week. Join Dr. Cora Allen-Savietta of Berry Consultants for her presentation on “Finding a Path To Prevention in Parkinson’s Disease: A Nested Platform Trial to Efficiently…

(1/n) New blog post from my colleague Joe Marion on prior distributions in CRMs. While we often discuss the “what” in design, Joe focuses on the equally important question of “how”, focusing on the information limited space of phase 1 trials.
berryconsultants.com/2023/10/13/blo…